Thailand to start producing anti-Covid nasal spray by Q3 2022; health department confirms 1,967 cases on Friday (June 17)

Image from The Nation Thailand/ANN

BANGKOK, June 17 (The Nation Thailand/ANN): Thailand's Government Pharmaceutical Organisation (GPO) is expected to start producing the antibody nasal spray solution to prevent Covid-19 by the third quarter of this year.

“GPO’s Viral Vaccine Division under the Department of Biological Products received a certificate of registration on June 6, allowing it to start manufacturing the solution containing the human IgG1 Anti-SARS-CoV-2 antibody,” GPO director Rangsee Padlee said.